PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22820128-0	2012	Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.	Pioglitazone	0-12	adiponectin receptor 1	Rattus norvegicus	56-63	
22820128-0	2012	Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.	Pioglitazone	0-12	adiponectin receptor 2	Rattus norvegicus	68-75	
22820128-2	2012	Former studies revealed that the regulation of adiponectin receptors expression differs in the receptor responses to pioglitazone.	Pioglitazone	117-129	adiponectin, C1Q and collagen domain containing	Rattus norvegicus	47-58	
22820128-4	2012	In the present study we investigated the effect of pioglitazone on the adiponectin receptors both in vitro and in vivo.	Pioglitazone	51-63	adiponectin, C1Q and collagen domain containing	Rattus norvegicus	71-82	
22820128-12	2012	PIO also increased AdipoR1 and AdipoR2 expression in coronary arteries, which were reduced notably in the DM group (p<0.05).	dm	106-108	adiponectin receptor 1	Rattus norvegicus	19-26	
22820128-12	2012	PIO also increased AdipoR1 and AdipoR2 expression in coronary arteries, which were reduced notably in the DM group (p<0.05).	dm	106-108	adiponectin receptor 2	Rattus norvegicus	31-38	
22820128-15	2012	CONCLUSION: In this study, we showed that treatment with PIO could ameliorate coronary insulin resistant and upregulate the expression of AdipoR1/R2.	Pemoline	57-60	adiponectin receptor 1	Rattus norvegicus	138-145